Adherence and persistence to second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

被引：0
|
作者：
Trivedi, Digisha
Amin, Shahla
Zhu, Ling
Joo, Sam
Kawabata, Hugh
Darkow, Theodore
Hebden, Tony
机构：
[1] Bristol Myers Squibb, Hlth Serv, Plainsboro, NJ USA
[2] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Pennington, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17009
引用
收藏
页数：1
相关论文
共 50 条
  • [31] DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA. EXPERIENCE IN A CENTER
    Navarro-Almenzar, Begona
    Perez, Lopez Raul
    Fernandez, Poveda Elena
    Leal, Rubio Juan Diego
    Sanchez, Villalobos Maria
    Serrano, Jara Claudia
    HAEMATOLOGICA, 2020, 105 : 394 - 395
  • [32] Dose De-Escalation of Second-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Major and Deep Molecular Response
    Gurianova, Margarita
    Shukhov, Oleg
    Chelysheva, Ekaterina
    Petrova, Anna
    Bykova, Anastasia
    Nemchenko, Irina
    Pospelova, Olga
    Julhakyan, Hunan
    Turkina, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S239 - S240
  • [33] Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors
    Breccia, Massimo
    Stagno, Fabio
    Gozzini, Antonella
    Abruzzese, Elisabetta
    Latagliata, Roberto
    Rossi, Antonella Russo
    Sora, Federica
    Porrini, Raffaele
    Vigneri, Paolo
    Trawinska, Malgorzata
    Montefusco, Enrico
    Sica, Simona
    Specchia, Giorgina
    Santini, Valeria
    Alimena, Giuliana
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (06) : 523 - 525
  • [34] Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
    Yang, Sen
    Zhang, Xiaoshuai
    Gale, Robert Peter
    Du, Xin
    Chen, Chun-yan
    Weng, Jian-yu
    Huang, Jian
    Li, Fei
    Zeng, Yun
    Xiao, Zhen
    Hu, Jian-da
    Yang, Li-jie
    Liu, Zhuo-gang
    Li, Guo-hui
    Sun, Xiu-li
    Yang, Wei
    Feng, Ru
    Han, Yan-qiu
    Jing, Yu
    Xu, Na
    Liu, Xiao-li
    Liu, Zhen-fang
    Wang, Xiao-dong
    Wu, Shi-xin
    Liang, Rong
    Zhang, Yan-li
    Yang, Yun-fan
    Zhu, Huan-ling
    Pan, Ling
    Meng, Li
    Zhao, Yan-hong
    Yi, Hai
    Liu, Yi-lan
    Zhang, Wei-hua
    Zheng, Yuan-jun
    Zhou, Ze-ping
    Chen, Su-ning
    Qiu, Hui-ying
    Li, Wei-ming
    Jia, Zhi-lin
    Bai, Yan-liang
    Lin, Li-e
    Liu, Bing-cheng
    Liu, Chun-shui
    Luo, Jian-min
    Meng, Jun-xia
    Sun, Zhi-qiang
    Zhang, Yan-qing
    Huang, Xiao-jun
    Jiang, Qian
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) : E183 - E186
  • [35] Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    Kim, Theo D.
    Schwarz, Michaela
    Nogai, Hendrik
    Grille, Peggy
    Westermann, Joerg
    Ploeckinger, Ursula
    Braun, Doreen
    Schweizer, Ulrich
    Arnold, Renate
    Doerken, Bernd
    le Coutre, Philipp
    THYROID, 2010, 20 (11) : 1209 - 1214
  • [36] THYROID DYSFUNCTION CAUSED BY SECOND-GENERATION TYROSINE KINASE INHIBITORS IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA
    Tothova, E.
    Kafkova, A.
    Stejskal, L.
    Hajek, R.
    HAEMATOLOGICA, 2016, 101 : 740 - 740
  • [37] Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment
    Trivedi, Digisha
    Landsman-Blumberg, Pamela
    Darkow, Theodore
    Smith, David
    McMorrow, Donna
    Mullins, C. Daniel
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (10): : 1006 - 1015
  • [38] Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment
    Chen, Lei
    Wu, Eric Q.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (11): : 1088 - 1088
  • [39] Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Fava, Carmen
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Wierda, William
    Thomas, Deborah
    Shan, Jianquin
    Cortes, Jorge
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (03) : 303 - 312
  • [40] Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia
    Klyuchnikov, Evgeny
    Schafhausen, Philippe
    Kroeger, Nicolaus
    Brummendorf, Tim H.
    Osanmaz, Okay
    Asenova, Svetlana
    Zabelina, Tatjana
    Ocheni, Sunday
    Ayuk, Francis
    Zander, Axel R.
    Bacher, Ulrike
    ACTA HAEMATOLOGICA, 2009, 122 (01) : 6 - 10
12345